The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.

Gina Kolata | NYTimes Health | Disclosure

This post first appeared on Think, please read the originial post: here

People also like

Sleep Apnea Reduced in People Who Took Weight-Loss Drug, Eli Lilly Reports